第8回OOTR年次学会

開催日時 2012年4月20日(金)- 21日(土) 開催場所 ウエスティン都ホテル京都
テーマ Cancer therapy- biology of cancer stem cells and cancer stroma, therapeutic resistance and cancer prevention 世話人 戸井 雅和(代表世話人・President, OOTR), Louis W.C. Chow(Executive Director, OOTR), Nadir Arber
後援 文部科学省 がんプロフェッショナル養成プラン(京都大学医学研究科)
朝日新聞 京都総局
京都新聞社
京都府
京都市

Invited Specialists

(in alphabetical order)

ARBER Nadir Tel Aviv University (Israel)
Aspirin and colonoscopy can prevent CRC: Novel personalized approach
BARCELLOS-HOFF Mary Helen New York University (USA)
'TGFβ Inhibition improves cancer stem cell response to radiotherapy'
CAO Yihai Karolinska Institute (Sweden)
'Mechanisms of antiangiogenic cancer therapy'
CARMELIET Peter F Vesalius Research Center (Belgium)
'Controlling angiogenesis via endothelial metabolism'
CHOW Louis W C The University of Hong Kong (Hong Kong)
'Prevention of oncological diseases'
GASPARINI Giampietro San Filippo Neri Hospital (Italy)
'Antiangiogenic therapy of colorectal cancer: State of the art, challenges and future areas of research'
GUNZBURG Walter H University of Veterinary Medicine (Austria)
'Encapsulation of cells as an innovative therapy for the treatment of cancer and other severe diseases'
HUANG Chiun-Sheng National Taiwan University Hospital (Taiwan)
INAMOTO Takashi Tenri Health Care University (Japan)
INBAR Moshe Tel Aviv Medical Center & Tel Aviv University (Israel)
'Is breast cancer preventable?'
IWATA Hiroji Aichi Cancer Center Hospital (Japan)
KAKEYA Hideaki Kyoto University (Japan)
KROP Ian E Dana-Farber Cancer Institute (USA)
'Novel therapies for HER2-positive breast cancer'
KUMAR Rakesh George Washington University (USA)
'Genomic insights of Triple-Negative Breast Cancer'
KUROI Katsumasa Tokyo Metropolitan Cancer and Infectious Diseases Centre Komagome Hospital (Japan)
LEE Soo-Jung Yeungnam University Hospital (Korea)
NAKAMURA Seigo Showa University (Japan)
OHASHI Yasuo The University of Tokyo (Japan)
'Epidemiology and Prevention of Breast Cancer -with specific emphasis on dietary habit-'
OHNO Shinji National Kyushu Cancer Center (Japan)
PEGRAM Mark D Stanford University (USA)
'Future perspective of triple negative cancer treatment'
RUGO Hope S UCSF Helen Diller Family Comprehensive Cancer Center (USA)
'Enhancing efficacy of chemotherapy in Triple Negative/Basal-like Breast Cancer (TNBC) by targeting macrophages '
SABE Hisataka Hokkaido University (Japan)
'RTKs-GEP100-Arf6-AMAP1 pathway mediates cancerous EMT in response to mutant p53 and TGFβ1 signaling'
SASANO Hironobu Tohoku University (Japan)
'Biological and morphological changes of breast cancer following neoadjuvant therapy'
SATO Fumiaki Kyoto University (Japan)
'Epigenetics-regulated microRNAs related with epithelial-mesenchymal transition of breast cancer cells'
SAYA Hideyuki Keio University (Japan)
'Novel strategies for cancer stem cells'
SCHERER Stefan J Roche / Genentech Inc. (USA)
'Molecular biomarkers for bevacizumab'
SUGIE Tomoharu Kyoto University Hospital (Japan)
TOI Masakazu Kyoto University (Japan)
WINER Eric P Dana-Farber Cancer Institute (USA)
Late Recurrence of ER+ Breast Cancer: Unresolved Clinical Challenge
YOSHIKAWA Kiyotsugu Kyoto University (Japan)
YU John Institute of Cellular and Organismic Biology and Genomics Research Centre, Academia Sinica (Taiwan)
'Harnessing human ES biomarkers for cancer therapeutics'

* The above is subject to change.